CAPO News


  • 22 Sep 2021 2:06 PM | John Chagnon (Administrator)

    CAPO is inviting a member of the public to join the CAPO board as a patient and/or family representative to raise awareness of the challenges and priorities of patients and families affected by cancer. The patient and/or family representative will provide strategic advice and guidance to enhance how CAPO communicates its work to the membership and external stakeholders as it relates to person-centred and quality psychosocial care. The Member will also provide strategic advice and guidance to the CAPO Board in its efforts to increase revenues through fundraising efforts and other funding opportunities.

    Role/Responsibility for the Patient and/or Family Representative on the CAPO Board:
    • Share vision and ideas for person-centred care based on patient and family member experience; provide clarification and context as needed on patient and family-related issues
    • Provide strategic advice and guidance to fundraise and/or secure other funds through granting agencies to advance the mission to ensure equity in access to psychosocial care across Canada.
    • Regularly attend and be an active participant in monthly board teleconference/Zoom (in a non-voting capacity)
    • Participate on other CAPO working committees and offer advice on other CAPO initiatives and strategic priorities as needed
    • Represent the CAPO board as a Patient and/or Family Representative at speaker engagements and committee work internal and external to CAPO  
    Eligibility/Term/Application process:
    • Cancer Patient and/or family member who can provide strategic advice and guidance on communication strategies and/or fundraising. A family member may include a person who is not directly related to a survivor yet can identify themselves as a member of a patient’s care team. 
    • Two-year term 
    How to submit interest:
    • Please email the following information by October 15th to: [email protected]
      • First and Last name
      • Email address
      • Description of Patient Experience
      • City and Province/Territory located in
      • Twitter handle


  • 23 Jul 2021 11:14 AM | Peter Traversa (Administrator)

    We are pleased to announce our affiliated journal, Current Oncology, has received an updated Impact Factor in the 2020 edition of the Journal Citation Reports® released in June 2021. An increase to 3.677 from 2.257.


  • 15 May 2021 10:31 AM | Peter Traversa (Administrator)

    We are offering two free publications for our Special Issue on the Supportive Care Needs of Cancer Patients and Family Caregivers in Current Oncology. 

    Submit your abstract to [email protected] by May 31, 2021 to be considered for one of two free publications. Submitted abstracts will be evaluated based on innovation, scientific merit, need and whether they have an alternative source of funding.

    The deadline for full manuscript submission is July 31, 2021The publication fee is 1600 CHF.

    For more information about the special issue, please see: https://www.mdpi.com/journal/curroncol/special_issues/supportivecare_cancerpatients

    Sincerely,

    Dr. Jackie Bender and Dr. Sylvie Lambert
    Guest Editors of the Special Issue in Current Oncology

  • 7 May 2021 9:34 AM | Peter Traversa (Administrator)

    Harvey Max Chochinov, OC OM MD PhD FRCPC FRSC FCAHS | Winnipeg, MB

    Distinguished Professor of Psychiatry at the University of Manitoba and Senior Scientist at the Research Institute of Oncology and Haematology, CancerCare Manitoba, is one of the world’s most innovative and influential proponents of improved and expanded palliative care across multiple dimensions of life-limiting or life-ending condition.  Dr. Chochinov’s pioneering work has significantly advanced effective recognition and treatment of end-of-life distress, depression, desire for death and vulnerability.  His empirical research provides guidelines for dignity conserving palliative care and psychosocial intervention and is helping to assure that our medical management of dying and death does not disregard alleviable pain nor violate the dignity of patients and their families.

    Dr. Chochinov is Co-Founder and former chair (2001-2015) of the Canadian Virtual Hospice (CVH), the world’s most comprehensive online platform providing information and support to patients, families and health providers on issues related to palliative care and bereavement.  His award-winning book Dignity Therapy: Final Words for Final Days is a profound and beautiful meditation on human mortality and a blueprint for the palliative intervention developed by Dr. Chochinov and his research colleagues.

    VIEW THE FULL MEDIA RELEASE HERE

    ENGLISH

    FRENCH

  • 21 Apr 2021 5:13 PM | Peter Traversa (Administrator)

    The Department of Psychosocial Oncology and Rehabilitation (Tom Baker Cancer Centre, Calgary Alberta) and the Division of Psychosocial Oncology (Cumming School of Medicine, University of Calgary) are recruiting a clinical academic Fellow for the 2022-23 academic year. This opportunity is for interdisciplinary professionals (completing training or fully licensed) who are seeking one year of specialized training in Psychosocial Oncology. Interested applicants are encouraged to send a letter of interest by May 15, 2021. Following an expression of interest, a single chosen candidate will build a tailored application collaboratively with our program, and apply by Aug 31, 2021. Competition results will be announced around November 2021.

    Members can learn more about this opportunity HERE

  • 19 Apr 2021 4:08 PM | Peter Traversa (Administrator)
    The Annual General Meeting of the Canadian Association of Psychosocial Oncology we will held at 12 p.m. EDT, Tuesday, May 25, 2021.

    Typically the association holds the annual meeting in conjunction with CAPO conference which is normally held in the spring. This year the conference will be held in June and will again be virtual.
     
    This later date poses a challenge for scheduling the CAPO Annual General Meeting. Our bylaws state that our AGM is to be held within 150 days of the end of our fiscal year (December 31). To ensure compliance with our bylaws the 2021 annual meeting will be held virtually. The bylaws provide for holding meetings electronically. The platform to be used will allow for attendance by Webinar.

    MEMBERS RSVP HERE


  • 3 Mar 2021 3:51 PM | John Chagnon (Administrator)


    Dear colleagues,

    As the Guest Editors of the Special Issue in Current Oncology described below, we encourage you to consider contributing a paper.

    Special Issue Title: Supportive Care Needs of Cancer Patients and Caregivers

    Website: https://lnkd.in/gdncaCj

    Deadline for manuscript submissions: July 31, 2021

    Papers will be published on an ongoing basis, immediately upon acceptance after peer review (generally within one week). A publication fee of 1200 CHF will be applied for each accepted paper submitted in 2021 (papers submitted after 30 June 2021 the APC will be 1600 CHF). No extra fees will be applied for color figures.

    As an incentive, we have two free publications to offer. To apply to have your paper published free of charge, please send us an abstract and tentative title by May 31, 2021. Submitted abstracts will be evaluated based on innovation, scientific merit, need and whether they have an alternative source of funding.

    Sincerely,

    Dr. Jackie Bender and Dr. Sylvie Lambert

    CAPO members can access the discount code and more information by going to Member Resources.

  • 2 Mar 2021 9:14 AM | John Chagnon (Administrator)


    Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. Dr. Shahid Ahmed from the University of Saskatchewan has served as Editor-in-Chief of Current Oncology since June 2023. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, and Scopus. Current Oncology received an increased Impact Factor for 2023 of 2.8, following an increased CiteScore of 3.3. Current Oncology now ranks in Q2 in the “Oncology” category (157/322) which represents our ranking relative to other journals in the same field. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.

    CAPO members enjoy author fee discounts with Current Oncology.  Email Karen for more info at [email protected].

    NOTE:  When you apply for research funding, please inquire whether your granting agency allows the costs of open access publishing, such as Article Processing Charges, to be included in the grant budget.  More and more, granting agencies are encouraging or even requiring that all papers resulting from funded research must be published in Open Access journals.

  • 17 Mar 2020 2:48 PM | John Chagnon (Administrator)

    CAPO Statement on COVID19

    Dear Members of the CAPO Community,

    These are incredibly difficult times full of uncertainty and fear. For our patients, colleagues and loved ones living with cancer, things are especially challenging.

    As always, the psychosocial well-being of our patients, colleagues and family members is our utmost priority. 

    We also understand that there is an overwhelming amount of information circulating regarding COVID-19.

    We have gathered the following resources to help you navigate this unprecedented time.

    As of right now, CAPO's 35th Annual Conference scheduled for July 15 to 17 in St. John’s, Newfoundland, is planned to proceed as scheduled. We are however monitoring the situation very closely and will advise if this changes. 

    WEBINAR – MARCH 20, 2020. Dr. Doris Howell: Proactive remote monitoring and real-time symptom management using mobile technology: a feasibility study. Please join us.

    As a community – we are here for you.

  • 5 Mar 2020 3:14 PM | John Chagnon (Administrator)

    March 6 is World Lymphedema Day! Lymphedema is chronic inflammatory condition that can develop after cancer treatment. Download the poster



The Canadian Association of
Psychosocial Oncology (CAPO)

189 Queen Street East, Suite 1
Toronto, ON M5A 1S2
P. 416-968-0207
[email protected]

Facebook Logo    twitter x logo    linkedin logo    linkedin logo

Privacy Policy | CAPO By-laws
© 1993-2024 - CAPO/ACOP

The Canadian Association of Psychosocial Oncology • Association Canadienne d'Oncologie Psychosociale
Website powered by Funnel Communications